Prognostic Value of NT-proBNP in Extracorporeal Membrane Oxygenation-Assisted Cardiogenic Shock Patients: A 5-Year Single-Center Retrospective Analysis
DOI:
https://doi.org/10.59958/hsf.8193Keywords:
NT-proBNP, venoarterial extracorporeal membrane oxygenation, cardiogenic shock, predictive valueAbstract
Background: This study aimed to evaluate the predictive value of N-terminal pro-brain natriuretic peptide (NT-proBNP) for venoarterial extracorporeal membrane oxygenation (VA-ECMO)-assisted clinical outcomes in adult patients with cardiogenic shock (CS). Methods: Our study included the demographic information and clinical data of 77 CS patients who underwent VA-ECMO-assisted therapy in our center between January 2016 and January 2021. The prognostic value of NT-proBNP in these patients was assessed. Results: Statistical analyses were performed using the chi-square or Fisher's exact tests. Among the study participants, the highest NT-proBNP values after VA-ECMO assistance were observed in CS patients who had died versus those undergoing rehabilitation (21,439.62 vs. 13,568.26 pg/mL). Mean NT-proBNP values at the time of ECMO weaning (18,170.95 vs. 8472.8 pg/mL) and before discharge (22,183.35 vs. 5646.197 pg/mL) were higher in the death group. Age, sepsis-related organ failure assessment (SOFA) scores, creatinine, platelet, urea nitrogen, total bilirubin, and lactic acid levels; mean arterial pressure; creatinine level at the point of ECMO weaning, NT-proBNP value before discharge, percentage of left ventricular ejection fraction were reliable predictors of mortality. The area under the receiver operating characteristic curve (AUC–ROC) was >0.70 (p < 0.05). The AUC–ROC of the pre-discharge NT-proBNP was 0.873; these NT-proBNP values had the best predictive ability regarding patient death. Conclusion: Among CS patients who received VA-ECMO assistance, NT-proBNP values at each assistance point had important patient-related diagnostic and predictive values. Pre-discharge NT-proBNP values were the best predictors of patient prognosis.
References
Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, et al. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry. JACC. Cardiovascular Interventions. 2016; 9: 341–351. https://doi.org/10.1016/j.jcin.2015.10.039.
Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. Journal of the American College of Cardiology. 2015; 65: e7–e26. https://doi.org/10.1016/j.jacc.2015.03.036.
Musiał R, Moncznik P, Śmiałek P, Stoliński J, Sadowski J, Drwiła R. Veno-arterial extracorporeal membrane oxygenation for short-term mechanical circulation support in adults with cardiogenic shock: a single centre experience. Kardiologia Polska. 2016; 74: 1477–1484. https://doi.org/10.5603/KP.a2016.0087.
Luyt CE, Landivier A, Leprince P, Bernard M, Pavie A, Chastre J, et al. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock. Journal of Critical Care. 2012; 27: 524.e7–524.e14. https://doi.org/10.1016/j.jcrc.2011.12.009.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016; 37: 2129–2200. https://doi.org/10.1093/eurheartj/ehw128.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr, Colvin MM, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology. 2017; 70: 776–803. https://doi.org/10.1016/j.jacc.2017.04.025.
Chinese Society of Cardiovascular Diseases, Chinese Journal of Cardiovascular Diseases Editorial Board. China Heart Failure Diagnosis and Treatment Guidelines 2014. Chinese Society of Cardiology. 2014; 42: 98–122. (In Chinese)
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. The New England Journal of Medicine. 1999; 341: 625–634. https://doi.org/10.1056/NEJM199908263410901.
Extracorporeal life support professional committee of Chinese Medical Association. Expert consensus on extracorporeal membrane oxygenation circulation assistance in adults. National Medical Journal of China. 2018; 98: 886–894. (In Chinese)
Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Annals of Internal Medicine. 1999; 131: 47–59. https://doi.org/10.7326/0003-4819-131-1-199907060-00010.
Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Failure Reviews. 2014; 19: 453–470. https://doi.org/10.1007/s10741-014-9442-y.
Metra M, Nodari S, Parrinello G, Specchia C, Brentana L, Rocca P, et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. European Journal of Heart Failure. 2007; 9: 776–786. https://doi.org/10.1016/j.ejheart.2007.05.007.
Li Y, Zeng W, Sun LB, Han J, Xu CL,Zhang HB, et al. Clinical application of extracorporeal membrane oxygenation circuit in place of cardiopulmonary bypass.Clinical Medicine Of China. 2008; 24: 478–480. (In Chinese)
Kaestner F, Rapp D, Trudzinski FC, Olewczynska N, Wagenpfeil S, Langer F, et al. High Serum Bilirubin Levels, NT-pro-BNP, and Lactate Predict Mortality in Long-Term, Severely Ill Respiratory ECMO Patients. ASAIO Journal. 2018; 64: 232–237. https://doi.org/10.1097/MAT.0000000000000610.
Partridge EA, Hanna BD, Rintoul NE, Herkert L, Flake AW, Adzick NS, et al. Brain-type natriuretic peptide levels correlate with pulmonary hypertension and requirement for extracorporeal membrane oxygenation in congenital diaphragmatic hernia. Journal of Pediatric Surgery. 2015; 50: 263–266. https://doi.org/10.1016/j.jpedsurg.2014.11.009.
Huang SC, Wu ET, Ko WJ, Lai LP, Hsu J, Chang CI, et al. Clinical implication of blood levels of B-type natriuretic peptide in pediatric patients on mechanical circulatory support. The Annals of Thoracic Surgery. 2006; 81: 2267–2272. https://doi.org/10.1016/j.athoracsur.2005.12.061.
Kim HS, Lee KJ, Ha SO, Han SJ, Park KH, Lee SH, et al. Brain natriuretic peptide levels predict 6-month mortality in patients with cardiogenic shock who were weaned off extracorporeal membrane oxygenation. Medicine. 2020; 99: e21272. https://doi.org/10.1097/MD.0000000000021272.
Published
How to Cite
Issue
Section
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
